Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Baeck

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
JAMA Dermatology|December 23, 2020
Emerging Evidence of the Direct Association Between COVID-19 And Chilblains-ReplyMarie Baeck, Anne Herman
Contact Dermatitis|October 25, 2017
Airborne contact dermatitis in a patient with type I and IV sensitivity to chicoryAnne Herman, Marie Baeck
Contact Dermatitis|February 2, 2021
Sensitization to isobornyl acrylate in a tertiary Belgian hospitalAnne Herman, Marie Baeck
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 19, 2020
COVID toes: where do we stand with the current evidence?Marie Baeck, Anne Herman
Contact Dermatitis|August 8, 2009
Patients with airborne sensitization/contact dermatitis from budesonide-containing aerosols 'by proxy'Marie Baeck, An Goossens
Contact Dermatitis|October 7, 2011
Immediate and delayed allergic hypersensitivity to corticosteroids: practical guidelinesMarie Baeck, An Goossens
Contact Dermatitis|August 18, 2012
Occupationally induced fixed drug eruption caused by a non-steroidal anti-inflammatory agentFatima Lamchahab, Marie Baeck
Contact Dermatitis|August 12, 2024
Tralokinumab-induced injection-site reactionsAxel De Greef, Marie Baeck
JAMA Dermatology|October 9, 2024
Tralokinumab and Acitretin for the Treatment of Lamellar IchthyosisAxel De Greef, Marie Baeck
Journal of the European Academy of Dermatology and Venereology : JEADV|May 29, 2024
Combination of Janus kinase inhibitor and biologic for recalcitrant severe atopic dermatitisAxel De Greef, Marie Baeck
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
JAMA Dermatology|December 23, 2020
Emerging Evidence of the Direct Association Between COVID-19 And Chilblains-ReplyMarie Baeck, Anne Herman
Contact Dermatitis|October 25, 2017
Airborne contact dermatitis in a patient with type I and IV sensitivity to chicoryAnne Herman, Marie Baeck
Contact Dermatitis|February 2, 2021
Sensitization to isobornyl acrylate in a tertiary Belgian hospitalAnne Herman, Marie Baeck
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 19, 2020
COVID toes: where do we stand with the current evidence?Marie Baeck, Anne Herman
Contact Dermatitis|August 8, 2009
Patients with airborne sensitization/contact dermatitis from budesonide-containing aerosols 'by proxy'Marie Baeck, An Goossens
Contact Dermatitis|October 7, 2011
Immediate and delayed allergic hypersensitivity to corticosteroids: practical guidelinesMarie Baeck, An Goossens
Contact Dermatitis|August 18, 2012
Occupationally induced fixed drug eruption caused by a non-steroidal anti-inflammatory agentFatima Lamchahab, Marie Baeck
Contact Dermatitis|August 12, 2024
Tralokinumab-induced injection-site reactionsAxel De Greef, Marie Baeck
JAMA Dermatology|October 9, 2024
Tralokinumab and Acitretin for the Treatment of Lamellar IchthyosisAxel De Greef, Marie Baeck
Journal of the European Academy of Dermatology and Venereology : JEADV|May 29, 2024
Combination of Janus kinase inhibitor and biologic for recalcitrant severe atopic dermatitisAxel De Greef, Marie Baeck
Pageof 10